Prazosin (Minipress)

What it treats

Prazosin is approved by the U.S. Food and Drug Administration for hypertension. In psychiatry it's used off-label for PTSD-related nightmares and sleep disruption. The VA/DoD Clinical Practice Guideline for PTSD covers it: the recommendation is qualified because trial results have been mixed, but for many patients (especially those with prominent nightmares and adrenergic-flavored insomnia) it helps.

It doesn't treat the daytime symptoms of PTSD (avoidance, hypervigilance, intrusion) except indirectly, by helping sleep. It isn't a substitute for trauma-focused therapy, which is the first-line treatment for PTSD in guidelines.

How it works

During sleep, the sympathetic nervous system is meant to quiet down. In PTSD, that quieting is often incomplete, and adrenergic activity spills into REM sleep, driving arousals and nightmares. Prazosin blocks alpha-1 receptors in the brain and body. Blocking the central adrenergic signal is thought to reduce the noradrenergic drive that fuels trauma nightmares and REM disruption.

The blood-pressure effect is a genuine second job. Prazosin blocks alpha-1 receptors on peripheral blood vessels too, and that's what causes the first-dose hypotension warning.

Receptor mechanism (detail)

Prazosin is a selective alpha-1 adrenergic receptor antagonist. It works at both central alpha-1 receptors (relevant to the PTSD nightmare effect) and peripheral vascular alpha-1 receptors (relevant to blood pressure and orthostatic side effects). Selectivity for alpha-1 over alpha-2 is what distinguishes it from older non-selective adrenergic blockers.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual.

The standard start for PTSD nightmares is 1 mg at bedtime for the first few days, then titration by 1 to 2 mg per week as tolerated. Common effective doses are 2 to 15 mg at bedtime, with some patients needing higher. Men often reach higher effective doses than women in clinical practice.

The first dose is deliberately small because of the "first-dose phenomenon": syncope or significant hypotension after the very first dose. Starting at bedtime, when the person will be lying down, is one way to reduce that risk.

Some clinicians add a small morning or midday dose for patients who describe daytime hyperarousal, though the primary evidence is for a bedtime dose targeting nightmares.

Safety monitoring

• Blood pressure. Baseline sitting and standing. Orthostatic drop (systolic falling 20 mmHg or more standing) is a reason to slow the titration.
• First-dose syncope. Start with 1 mg at bedtime and warn the patient not to stand up quickly at night.
• Priapism. Rare but real, especially at higher doses. Any prolonged erection needs emergency attention.
• Falls in older adults. Any alpha blocker adds to fall risk. Weigh carefully.
• Combination with PDE5 inhibitors (sildenafil, tadalafil, vardenafil). Additive hypotension. Timing separation and dose caution needed.
• Cataract surgery. Intraoperative floppy iris syndrome has been reported. Tell the ophthalmologist.

What to expect

Common side effects

• Dizziness, especially when standing up.
• Headache.
• Drowsiness.
• Fatigue.
• Nasal congestion.
• Dry mouth.
• Rebound tachycardia in some patients.
• Mild edema.

Most of these are worse at the start and improve. Slow titration is the main way to reduce them.

Serious side effects and warnings

• First-dose syncope. Well-described. Start at 1 mg at bedtime, warn the patient.
• Orthostatic hypotension. Especially in older adults, patients on other antihypertensives, or those who are volume-depleted.
• Priapism. Rare but real. Any erection lasting over 4 hours is an emergency.
• Intraoperative floppy iris syndrome. Tell the ophthalmologist before cataract surgery.
• Additive hypotension with PDE5 inhibitors, nitrates, other antihypertensives, and alcohol.
• Rebound hypertension isn't a classic prazosin problem the way it is with clonidine, but abrupt stopping in someone using it for blood pressure control isn't ideal.

Sexual and relational effects

Sexual side effects are usually mild. Some patients notice retrograde ejaculation or reduced ejaculatory volume, more common with related alpha blockers (tamsulosin) than prazosin. Priapism is rare but needs to be known. On the positive side, better sleep often improves overall functioning and connection with a partner, which matters in PTSD care where the nights have been a battleground. If a partner shares the bed and the nightmares have been affecting both people, a good response to prazosin can be a real relational shift.

Weight, appetite, and sleep

Weight change on prazosin is usually minimal. Appetite is unaffected. Sleep is the whole point: on a good dose, nightmares decrease and sleep quality improves. Some patients report vivid but non-distressing dreams as the doses go up; others describe fewer dreams overall.

Starting and dosing basics

This section is general background, not a dosing instruction for any individual.

The typical PTSD nightmare start is 1 mg at bedtime for 3 to 7 nights, then increase by 1 to 2 mg per week as tolerated. Common effective ranges are 2 to 15 mg at bedtime. Blood pressure (sitting and standing) is checked at each step. Some patients need higher doses; some do fine at 2 or 3 mg.

Taking it at bedtime, not standing up quickly during the night, and staying hydrated all help with the orthostatic side.

Missed doses and interactions

If a dose is missed, skip it and take the next scheduled dose. Don't double up, especially for a bedtime medication.

Interactions that matter:

• Other antihypertensives. Additive blood pressure lowering. Coordination between prescribers matters if hypertension is being treated by someone else.
• PDE5 inhibitors (sildenafil, tadalafil, vardenafil). Additive hypotension. Separation of doses and dose caution needed. Some clinicians avoid the combination.
• Nitrates. Additive hypotension.
• Alcohol. Additive hypotension and dizziness.
• Beta blockers. First-dose hypotension can be more pronounced.
• NSAIDs. Can blunt the blood pressure effect.

Stopping and tapering

Prazosin doesn't cause classic physical dependence, and there's no defined withdrawal syndrome. For PTSD nightmare use, some patients stop after months and stay better. Others notice nightmares return and go back on it. A gradual taper over 1 to 2 weeks is reasonable, especially at higher doses, because a sudden stop can rebound sympathetic tone.

If it's being used for blood pressure, coordinate any stopping with the prescriber managing that.

Pregnancy and breastfeeding

Data on prazosin in pregnancy is limited but reassuring for the pregnancy category it holds. It's occasionally used for hypertension in pregnancy. Anyone who is pregnant, planning a pregnancy, or breastfeeding should talk it through with a prescriber, weighing the risks of untreated PTSD nightmare symptoms against the medication.

Cost and generic availability

Prazosin has been generic for decades and is inexpensive. Coverage is essentially always straightforward.

Common questions

How long does it take to work for nightmares? Some people notice a change within one to two weeks at a low dose. Many need to titrate up over four to eight weeks before the effect is clear.

Is this a sleeping pill? No. It doesn't sedate the way a Z-drug or benzodiazepine does. It quiets the adrenergic drive that fuels trauma nightmares. Some people notice mild drowsiness early, but that isn't the mechanism.

Is it addictive? No. Prazosin isn't controlled and doesn't produce a high.

Can I take it with my blood pressure medication? Sometimes yes, but the dosing has to be coordinated because effects add up. Tell whoever manages the blood pressure.

Will I have to be on it forever? Not necessarily. Some people use it during an active phase of PTSD treatment and taper off once therapy and time have done their work. Others benefit from staying on a low dose long-term.

Questions to ask your prescriber

• What are we hoping this treats, and how will we know it's working?
• What blood pressure changes should I watch for at each step up?
• What do I do if I feel faint on the first dose?
• Are any of my current medications a problem to combine with prazosin?
• When would we plan to try stopping?

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes, and current as of June 8, 2026.

• U.S. Food and Drug Administration. Prazosin (Minipress) prescribing information.
• MedlinePlus, U.S. National Library of Medicine. Prazosin.
• DailyMed, U.S. National Library of Medicine. Prazosin hydrochloride capsules.
• VA/DoD Clinical Practice Guideline for the Management of PTSD. Recommendations on pharmacologic treatment of PTSD nightmares.
• National Institute of Mental Health. Post-traumatic stress disorder.